MERCK RESEARCH LABORATORIES
Merck Research Laboratories discovers and develops medicines for cancer and neurodegenerative disorders. The company was founded in 2004 and is based in Boston, Massachusetts. Merck Research Laboratories operates as a subsidiary of Merck & Co. Inc.
MERCK RESEARCH LABORATORIES
Industry:
Clinical Trials Health Care Medical
Founded:
2004-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.merck.com
Status:
Active
Contact:
(908)740-4000
Similar Organizations
Clínica AMO
Clínica AMO operates eight clinics, providing advanced cancer treatment in the largest cities of the State of Bahia.
ConvaTec
ConvaTec specializes in the development, manufacture, distribution of single-use devices to hospitals and healthcare sectors.
Intelligent Healthcare
Delivered data insights to physicians and administrators for provider organizations to meet the needs of Accountable Care
MedWatch
MedWatch is a full-services medical management firm that provides clinical risk management solutions, health plans and healthcare.
Sentinel Diagnostics
Sentinel Diagnostics works to the research and development of innovative in-vitro diagnostic medical devices.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-06-01 | Visterra | Merck Research Laboratories investment in Series C - Visterra | 23.1 M USD |
| 2014-10-31 | Imago BioSciences | Merck Research Laboratories investment in Series A - Imago BioSciences | 26.5 M USD |
| 2014-10-02 | Visterra | Merck Research Laboratories investment in Series B - Visterra | 30 M USD |
Key Employee Changes
Official Site Inspections
http://www.merck.com
- Host name: 192.0.66.119
- IP address: 192.0.66.119
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Merck Research Laboratories"
Business development and licensing (BD&L) - Merck.com
Our BD&L organization works with a broad range of partners — from early-stage science to clinical-stage programs — to deliver therapies to waiting patients.See details»
Merck Research Laboratories Facilities Designated as …
Oct 17, 2016 · announced today that Merck Research Laboratories (MRL) facilities in Rahway, N.J., and West Point, Pa., have been designated as “Milestones in Microbiology” sites by the American Society for Microbiology …See details»
Merck CEO Announces Structure and Global Leadership Team for …
Aug 31, 2009 · Merck Research Laboratories The new Merck Research Laboratories (MRL) will be led by Peter S. Kim, Ph.D., currently executive vice president and president of MRL.See details»
Merck | Home
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We follow the science where we can make the greatest difference, now and in the future. Clinical trials help …See details»
MRL Ventures Fund - Crunchbase Investor Profile
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund. MRL Ventures Fund invests in early to late-stage biotechnology and healthcare companies, focusing on therapeutics. Their investment strategy is …See details»
Research & Development Locations | Merck Careers
Learn more about Merck's Research & Development Division. Explore current job opportunities within Research & Development at Merck. Discover the locations where our research happens.See details»
Merck Announces Organizational Transformation of …
Feb 7, 2022 · Merck, a leading science and technology company, today announced several organizational changes and a new operating model to support the long-term growth strategy of the Life Science business sector and to better …See details»
Meet the Merck Management Team - Company
Discover the team that leads Merck. Get to know the Merck management team, the founding family and how they guide the company!See details»
Group Structure - Merck Annual Report 2020
Mar 4, 2021 · General Disclosures (1) Company information (2) Reporting principles (3) Discretionary decisions and sources of estimation uncertainty (4) Subsequent eventsSee details»
Org Chart Merck Research Laboratories - The Official Board
Merck Research Laboratories is followed by less than 10 members. Unfortunately, you don't own enough credit to see this new org chart.See details»
Merck Announces Retirement of Dr. Roy D. Baynes; Dr. Eliav Barr ...
Mar 23, 2022 · Most recently he led MRL’s Global Medical Affairs organization from 2018 to January 2022, significantly expanding Merck’s scientific engagement and implementation …See details»
Jason Ruth - Merck | LinkedIn
Jun 4, 2021 · After more than a decade of leading and building SmartLabs, a company that has transformed how research is translated into treatments for patients, I… Experience: Merck · …See details»
Create a diversity, equity and inclusion strategy that works - Korn …
Aug 12, 2021 · Diversity, equity and inclusion have been part of Merck’s mission and strategy for some time, but MRL wanted to go beyond the numbers and embed diversity, equity and …See details»
Analytical Research and Development (AR&D) - Merck
Analytical Research and Development (AR&D) aims to advance the Merck pipeline from discovery through commercial filing and launch by delivering integrated physical, analytical, and …See details»
Merck CEO Announces Structure And Global Leadership Team For …
Sep 1, 2009 · Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. recently announced a new organizational structure and named top management and …See details»
Merck Announces Retirement of Dr. Roger M. Perlmutter; Dr. Dean …
Oct 2, 2020 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Roger M. Perlmutter will be …See details»
Merck & Co., Inc. (MRK): Among the Most Promising Cancer …
3 days ago · We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. …See details»
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating …
3 days ago · RAHWAY, N.J., November 25, 2024--Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim AnalysisSee details»
Research - Merck.com
Learn about Merck's research and products by getting to know the science, strategy and brains behind the innovations.See details»
Research | Merck
Merck translates science and technology into innovative products and partnerships. Find out how we use research and development to improve lives.See details»